v3.25.1
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
May 04, 2025
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on the Company’s share-based compensation expenses.


    Three Months Ended     Six Months Ended  
   
May 4,
   
April 28,
   
May 4,
   
April 28,
 
     2025      2024      2025      2024  
Expense reported in:
                       
Cost of goods sold
 
$
785
   
$
669
    $ 1,562     $ 1,263  
Selling, general, and administrative
   
2,288
     
2,987
      4,556       4,737  
Research and development
   
302
     
270
      592       499  
Total expense incurred
 
$
3,375
   
$
3,926
    $ 6,710     $ 6,499  
                                 
Expense by award type:
                               
Restricted stock awards
 
$
2,809
   
$
3,926
    $ 6,086     $ 6,499  
Restricted stock units
    509       -       509       -  
Employee stock purchase plan
   
57
     
-
      115       -  
Total expense incurred
 
$
3,375
   
$
3,926
    $ 6,710     $ 6,499  
                                 
Income tax benefits on share-based compensation
 
$
406
   
$
323
    $ 852     $ 421  
Restricted Stock Awards Activity The table below presents information on the Company’s restricted stock awards.


   
Three Months Ended
    Six Months Ended  
   
May 4,
   
April 28,
   
May 4,
   
April 28,
 
    2025
    2024
    2025
     2024  
Number of shares granted in period
   
237,738
     
-
      583,238       825,050  
Weighted-average grant-date fair value of awards (in dollars per share)
 
$
21.28
   
$
-
    $ 23.42     $ 29.77  
Compensation cost not yet recognized
 
$
27,028
   
$
28,695
    $ 27,028     $ 28,695  
Weighted-average amortization period for cost not yet recognized (in years)
   
3.0
     
3.1
      3.0       3.1  
Shares outstanding at balance sheet date
   
1,439,672
     
1,560,540
      1,439,672       1,560,540  
Restricted Stock Units Activity The table below presents information on the Company’s restricted stock awards.

        Three Months Ended         Six Months Ended  
   
May 4,
   
April 28,
   
May 4,
   
April 28,
 
   
2025
   
2024
   
2025
   
2024
 
Number of units granted in period
 

52,836
     
-
     
52,836
     
-
 
Weighted-average grant-date fair value of awards (in dollars per share)
 
$
22.52
   
$
-
   
$
22.52
   
$
-
 
Compensation cost not yet recognized
 
$
681
   
$
-
   
$
681
   
$
-
 
Weighted-average amortization period for cost not yet recognized (in years)
   
0.8
     
-
     
0.8
     
-
 
Restricted stock units outstanding at balance sheet date
   
33,966
     
-
     
33,966
     
-
 
Stock Options Activity The table below presents information on the Company’s stock options.


   
Three Months Ended
    Six Months Ended  
   
May 4,
   
April 28,
   
May 4,
   
April 28,
 
    2025      2024      2025     2024  
Number of options granted in period
   
-
     
-
      -       -  
Cash received from options exercised
 
$
26
   
$
119
    $ 1,298     $ 1,055  
Compensation cost not yet recognized
 
$
-
   
$
-
    $ -     $ -  
Weighted-average amortization period for cost not yet recognized (in years)
   
-
     
-
     
-
      -  
Outstanding and Exercisable Option
Information regarding outstanding and exercisable option awards as of May 4, 2025, is presented below.

Options
 
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life (in years)
   
Aggregate
Intrinsic
Value
 
Outstanding and exercisable at May 4, 2025
   
148,075
   
$
10.72
     
1.80
   
$
1,259